PMCK Berhad, an investment holding company, (0363) Fair Value & Analysis
Healthcare · MY · Market cap 218M MYR
Fair value as of: Jun 26, 2026
Analysis
PMCK Berhad, an investment holding company, (0363) currently trades at 0.2000 MYR, while our model-based Fair Value estimate is 0.1900 MYR — implying the stock looks roughly 5.0% overvalued today. We read business quality at 83/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
PMCK Berhad, an investment holding company, provides specialist consultant, healthcare support, and other services in Malaysia. The company offers specialist consulting services in the areas of anaesthesiology, emergency medicine, cardiology, dermatology, internal medicine, nephrology, obstetrics and gynaecology, ophthalmology, oral and maxillofacial surgery, orthodontics, orthopaedics, otorhinolaryngology, paediatrics, radiology, sports medicine, surgical/general surgery, and urology. It also provides healthcare support services comprising facilities services, ward services, clinical support services, and sale of medication, as well as nursing care services; and general dental, medical laboratory, and polyclinic services. The company was founded in 1991 and is headquartered in Alor Setar, Malaysia. PMCK Berhad is a subsidiary of Lim Kim Huat Holdings Sdn Bhd.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is PMCK Berhad, an investment holding company, (0363) undervalued?
What is the fair value of 0363?
What is the quality score of 0363?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.